Pazufloxacin
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(3R)-10-(1-aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-1H,7H- [1,3]oxazino[5,4,3-ij]quinoline-carboxylic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number |
127046-18-8 |
| ATC code | J01MA18 (WHO) |
| PubChem | CID 65957 |
| ChemSpider | 59360 |
| UNII |
4CZ1R38NDI |
| Chemical data | |
| Formula | C16H15FN2O4 |
| Molar mass | 318.29 g/mol |
| |
| |
| (verify) | |
Pazufloxacin (INN) is a fluoroquinolone antibiotic.[1] It is sold in Japan under the brand names Pasil and Pazucross.
See also
References
- ↑ Rubinstein, E. (2001). "History of quinolones and their side effects.". Chemotherapy. 47 Suppl 3: 3–8; discussion 44–8. doi:10.1159/000057838. PMID 11549783.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
